These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 16799960)

  • 1. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU.
    Zhao J; Zhang X; Shi M; Xu H; Jin J; Ni H; Yang S; Dai J; Wu M; Guo Y
    Hepatology; 2006 Jul; 44(1):205-15. PubMed ID: 16799960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of tumor suppressing gene TIP30/CC3 on the growth of tumor cells].
    Zhang X; Ouyang XN; Li XD; Zhao J; Guo YJ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):38-41. PubMed ID: 15670490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
    Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
    Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction of adenovirus vector expressing TIP30 and its tumor suppressive effect in vitro and in vivo].
    Zhang X; Zhao J; Li XD; Yuan CT; Wang HQ; Wu MC; Xiao H; Guo YJ
    Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):85-8. PubMed ID: 15059324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
    Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
    Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
    Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIP30 deficiency increases susceptibility to tumorigenesis.
    Ito M; Jiang C; Krumm K; Zhang X; Pecha J; Zhao J; Guo Y; Roeder RG; Xiao H
    Cancer Res; 2003 Dec; 63(24):8763-7. PubMed ID: 14695192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression.
    Zhao J; Ni H; Ma Y; Dong L; Dai J; Zhao F; Yan X; Lu B; Xu H; Guo Y
    Hum Pathol; 2007 Feb; 38(2):293-8. PubMed ID: 17097132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
    Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
    Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIP30 induces apoptosis under oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma.
    Zhao J; Chen J; Lu B; Dong L; Wang H; Bi C; Wu G; Guo H; Wu M; Guo Y
    Cancer Res; 2008 Jun; 68(11):4133-41. PubMed ID: 18519672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.
    Zhao J; Jin J; Zhang X; Shi M; Dai J; Wu M; Wang R; Guo Y
    Cancer Gene Ther; 2006 Apr; 13(4):420-7. PubMed ID: 16211087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma.
    Miao J; Chen GG; Chun SY; Chak EC; Lai PB
    Int J Oncol; 2004 Sep; 25(3):651-9. PubMed ID: 15289866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
    Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
    Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
    Yanase K; Yoshiji H; Ikenaka Y; Noguchi R; Kitade M; Kaji K; Yoshii J; Namisaki T; Yamazaki M; Asada K; Tsujimoto T; Akahane T; Uemura M; Fukui H
    Oncol Rep; 2007 Feb; 17(2):441-6. PubMed ID: 17203185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
    Wang H; Jiang H; Zhou M; Xu Z; Liu S; Shi B; Yao X; Yao M; Gu J; Li Z
    Cancer Lett; 2009 Jun; 279(1):30-8. PubMed ID: 19217205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.